Cargando…

Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 inhibitor use

BACKGROUND AND AIMS: It is currently unclear whether sodium–glucose co-transporter 2 (SGLT2) inhibitor administration can improve the insulin sensitivity as well as rapidly reduce plasma glucose concentrations in humans during the early phase of treatment initiation. This study aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Yuka, Otsuka, Yoshie, Ashida, Kenji, Nagayama, Ayako, Hasuzawa, Nao, Iwata, Shimpei, Hara, Kento, Tsuruta, Munehisa, Wada, Nobuhiko, Motomura, Seiichi, Tajiri, Yuji, Nomura, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354734/ https://www.ncbi.nlm.nih.gov/pubmed/32580152 http://dx.doi.org/10.1530/EC-20-0082

Ejemplares similares

Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3
por: Gobaru, Mizuki, et al.
Publicado: (2019)

Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment
por: Shikata, Masato, et al.
Publicado: (2020)

Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case Report
por: Nagayama, Ayako, et al.
Publicado: (2019)

Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy
por: Nagayama, Ayako, et al.
Publicado: (2021)

Eruptive xanthomas as a marker for metabolic disorders: A specific form of xanthoma that reflects hypertriglyceridemia
por: Ohtaki, Sohichiroh, et al.
Publicado: (2022)

Thyroid-related ophthalmopathy development in concurrence with growth hormone administration
por: Iwata, Shimpei, et al.
Publicado: (2021)

Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma
por: Matsuo, Yuko, et al.
Publicado: (2023)

Necessity of Utilizing Physiological Glucocorticoids for Managing Familial Mediterranean Fever
por: Ashida, Kenji, et al.
Publicado: (2020)

Case Report: Myxedema Coma Caused by Immunoglobulin A Vasculitis in a Patient With Severe Hypothyroidism
por: Ito, Hiroshi, et al.
Publicado: (2022)

Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in animal model of obese type 2 diabetes
por: Hara, Kento, et al.
Publicado: (2022)

Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury
por: Hasuzawa, Nao, et al.
Publicado: (2021)

Masked Diabetes Insipidus Hidden by Severe Hyponatremia: A Case of Pituitary Metastasis of Lung Adenocarcinoma
por: Watanabe, Miki, et al.
Publicado: (2020)

Distinct Relevance of Nightly Sleep Duration to Metabolic, Anthropometric, and Lifestyle Factors in Patients with Type 2 Diabetes
por: Nakayama, Hitomi, et al.
Publicado: (2020)

Brown adipose activation and reversible beige coloration in adipose tissue with multiple accumulations of (18)F‐fluorodeoxyglucose in sporadic paraganglioma: A case report
por: Terada, Eriko, et al.
Publicado: (2019)

IgG4-Related Membranous Nephropathy with Acute Nephrotic Syndrome During Successful Steroid Maintenance Treatment for Type 1 Autoimmune Pancreatitis
por: Ito, Hiroshi, et al.
Publicado: (2023)

Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats
por: Tokubuchi, Ichiro, et al.
Publicado: (2017)

Is the vesicular nucleotide transporter a molecular target of eicosapentaenoic acid?
por: Moriyama, Yoshinori, et al.
Publicado: (2022)

Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes
por: Oshige, Tamami, et al.
Publicado: (2019)

Effects of a sodium glucose co-transporter 2 selective inhibitor, ipragliflozin, on the diurnal profile of plasma glucose in patients with type 2 diabetes: A study using continuous glucose monitoring
por: Yamada, Kentaro, et al.
Publicado: (2015)

Dynamin-related protein 1 deficiency accelerates lipopolysaccharide-induced acute liver injury and inflammation in mice
por: Wang, Lixiang, et al.
Publicado: (2021)

Reduced Number of Remaining or Healthy Teeth in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study Assessed by Dentists or Dental Hygienists in Japan
por: Kurinami, Noboru, et al.
Publicado: (2023)

Possible renoprotective mechanisms of SGLT2 inhibitors
por: Nishiyama, Akira, et al.
Publicado: (2023)

A Case of Acute Exacerbation of Chronic Adrenal Insufficiency Due to Ipilimumab Treatment for Advanced Melanoma
por: Sakaguchi, Chihiro, et al.
Publicado: (2019)

Reduction of Proteinuria in a Patient With Primary Aldosteronism by Angiotensin II Receptor Blocker Administration
por: Rikitake, Junjiro, et al.
Publicado: (2022)

Anesthetic management of a Rett syndrome patient with apnea and epilepsy: a case report
por: Motomura, Yuka, et al.
Publicado: (2018)

A simplified prediction model for end-stage kidney disease in patients with diabetes
por: Inoguchi, Toyoshi, et al.
Publicado: (2022)

SGLT2 and cancer
por: Wright, Ernest M.
Publicado: (2020)

Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2
por: Oranje, Paul, et al.
Publicado: (2019)

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Prognostic Value of Carbohydrate Antigen 19‐9 and the Surgical Margin in Extrahepatic Cholangiocarcinoma
por: Yamamoto, Ryusei, et al.
Publicado: (2021)

A case of pancreatic head cancer with Trousseau’s syndrome treated with radical resection and anticoagulant therapy
por: Kitahama, Takumi, et al.
Publicado: (2023)

The authors reply: Re: Yamamoto R, Sugiura T, Ashida R, Ohgi K, Yamada M, Otsuka S, and Uesaka K. Prognostic value of carbohydrate antigen 19‐9 and the surgical margin in extrahepatic Cholangiocarcinoma. Ann Gastroenterol Surg. 2022;6:307–315
por: Yamamoto, Ryusei, et al.
Publicado: (2023)

Hepatopancreatoduodenectomy With Delayed Division of the Pancreatic Parenchyma: A Novel Technique for Reducing Pancreatic Fistula
por: Sugiura, Teiichi, et al.
Publicado: (2021)

Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanoma
por: Yano, Seiichi, et al.
Publicado: (2018)

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels
por: Suga, Takayoshi, et al.
Publicado: (2018)

Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Nakashoji, Ayako, et al.
Publicado: (2017)

SGLT5 Reabsorbs Fructose in the Kidney but Its Deficiency Paradoxically Exacerbates Hepatic Steatosis Induced by Fructose
por: Fukuzawa, Taku, et al.
Publicado: (2013)

SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice
por: Spatola, Leonardo, et al.
Publicado: (2017)

Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
por: Ghezzi, Chiara, et al.
Publicado: (2018)

Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1
por: Sayour, Alex Ali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8tthmorfcvauaeondkpnr2l4u0